Professor | Hanbin Lin | Asia Growth Partners

Name	Hanbin Lin
Contact Information	linhanbin@simm.ac.cn
Language ability	English, Chinese
Province	Shanghai

Name

Hanbin Lin

Contact Information

linhanbin@simm.ac.cn

Language ability

English, Chinese

Province

Shanghai

University/Lab Affiliation and Title	University of Chinese Academy of Sciences
Faculty	Medical School
Academic Background & Achievements	2010-09 to 2014-10 PhD in Pharmacology: University of Saskatchewan 2006-09 to 2010-07 Bachelor of Science: Beijing Institute of Technology
Work Experience	2021-03 to Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Doctoral Supervisor/Researcher/Director of Scientific Development Department 2014-11 to 2021-01 - Ottawa Heart Institute - Postdoctoral Fellow 2010-09 to 2014-10 - University of Saskatchewan - PhD in Pharmacology 2006-09 to 2010-07 - Beijing Institute of Technology - Bachelor of Science
Awards	Biolron 2023 Travel Scholarship (2023): Other Provincial and Ministerial Youth Top Talent Award (2022): First Prize, Provincial Shanghai Overseas Leading Talent Award (2021): First Prize, Provincial European Society of Cardiology Congress 2017 Young Investigator Award (2017): Other Ottawa Heart Institute Cardiac Research Endowed Fellowship (2017): Institute National Excellent Self-Funded International Student Scholarship (2014): Ministerial Arthur Symth PhD Scholarship (2013): Institute Canadian Institutes of Health Research Have a Heart Bursary (2012): National James Regan Graduate Scholarship Award in Cardiology Research (2012): Institute

University/Lab Affiliation and Title

University of Chinese Academy of Sciences

Faculty

Medical School

Academic Background & Achievements

2010-09 to 2014-10 PhD in Pharmacology: University of Saskatchewan
2006-09 to 2010-07 Bachelor of Science: Beijing Institute of Technology

Work Experience

2021-03 to Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Doctoral Supervisor/Researcher/Director of Scientific Development Department
2014-11 to 2021-01 - Ottawa Heart Institute - Postdoctoral Fellow
2010-09 to 2014-10 - University of Saskatchewan - PhD in Pharmacology
2006-09 to 2010-07 - Beijing Institute of Technology - Bachelor of Science

Awards

Biolron 2023 Travel Scholarship (2023): Other
Provincial and Ministerial Youth Top Talent Award (2022): First Prize, Provincial
Shanghai Overseas Leading Talent Award (2021): First Prize, Provincial
European Society of Cardiology Congress 2017 Young Investigator Award (2017): Other
Ottawa Heart Institute Cardiac Research Endowed Fellowship (2017): Institute
National Excellent Self-Funded International Student Scholarship (2014): Ministerial
Arthur Symth PhD Scholarship (2013): Institute
Canadian Institutes of Health Research Have a Heart Bursary (2012): National
James Regan Graduate Scholarship Award in Cardiology Research (2012): Institute

Areas of Focus	Cardiovascular Pharmacology Immunology Pathology
Publications	Mitofilin in Cardiovascular Diseases: Insights into the Pathogenesis and Potential Pharmacological Interventions., Hanbin Lin, 2024 Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis., Hanbin Lin, 2024 Multi-omics reveals the attenuation of metabolic cardiomyopathy in mice by alkaloids in extracts from Clausena lansium (Lour.) via the transition of gastrointestinal microbiota to an alternative homeostasis., Hanbin Lin, 2024 Response to programmed cell death protein 1 antibody in patients with Epstein-Barr virus-associated intrahepatic cholangiocarcinoma., Hanbin Lin, 2023 Iron homeostasis in the heart: Molecular mechanisms and pharmacological implications, Hanbin Lin, 2023 Research progress on effects of traditional Chinese medicine on myocardial ischemia-reperfusion injury: A review, Hanbin Lin, 2022 Progress in the treatment of diabetic peripheral neuropathy, Hanbin Lin, 2022 The progressive application of single-cell RNA sequencing technology in cardiovascular diseases, Hanbin Lin, 2022 Overview of the preparation method, structure and function, and application of natural peptides and polypeptides, Hanbin Lin, 2022 Innate immune Nod1/RIP2 signaling is essential for cardiac hypertrophy, - but requires mitochondrial antiviral signaling protein (MAVS) for signal transductions and energy balance, Hanbin Lin, 2020 COVID-19 and the Heart: ACE2 Level and the Company it Keeps Hold the Key, Hanbin Lin, 2020 Protection of the Transplant Kidney from Preservation Injury by Inhibition of Matrix Metalloproteinases, Hanbin Lin, 2016 Subthreshold nitric oxide synthase inhibition improves synergistic effects of subthreshold MMP ��2 MLCK ��mediated cardiomyocyte protection from hypoxic injury, Hanbin Lin, 2016 Inhibition of MMP-2 expression affects the levels of metabolic enzymes: Proteomic analysis of rat cardiomyocytes. Journal of Proteomics, Hanbin Lin, 2014 Inhibition of MMP-2 Expression with siRNA Increases Baseline Cardiomyocyte Contractility and Protects against Simulated Ischemic Reperfusion Injury, Hanbin Lin, 2014 Synergy in protection against cardiac ischemia/reperfusion injury: a novel therapeutic paradigm for the future, Hanbin Lin, 2013 Proteomic analysis of right and left cardiac ventricles under aerobic conditions and after ischemia/reperfusion, Hanbin Lin, 2012 Effect of the myosin light chain kinase inhibitor ML-7 on the proteome of hearts subjected to ischemia��reperfusion injury, Hanbin Lin, 2012

Areas of Focus

Cardiovascular Pharmacology
Immunology
Pathology

Publications

Mitofilin in Cardiovascular Diseases: Insights into the Pathogenesis and Potential Pharmacological Interventions., Hanbin Lin, 2024
Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis., Hanbin Lin, 2024
Multi-omics reveals the attenuation of metabolic cardiomyopathy in mice by alkaloids in extracts from Clausena lansium (Lour.) via the transition of gastrointestinal microbiota to an alternative homeostasis., Hanbin Lin, 2024
Response to programmed cell death protein 1 antibody in patients with Epstein-Barr virus-associated intrahepatic cholangiocarcinoma., Hanbin Lin, 2023
Iron homeostasis in the heart: Molecular mechanisms and pharmacological implications, Hanbin Lin, 2023
Research progress on effects of traditional Chinese medicine on myocardial ischemia-reperfusion injury: A review, Hanbin Lin, 2022
Progress in the treatment of diabetic peripheral neuropathy, Hanbin Lin, 2022
The progressive application of single-cell RNA sequencing technology in cardiovascular diseases, Hanbin Lin, 2022
Overview of the preparation method, structure and function, and application of natural peptides and polypeptides, Hanbin Lin, 2022
Innate immune Nod1/RIP2 signaling is essential for cardiac hypertrophy, - but requires mitochondrial antiviral signaling protein (MAVS) for signal transductions and energy balance, Hanbin Lin, 2020
COVID-19 and the Heart: ACE2 Level and the Company it Keeps Hold the Key, Hanbin Lin, 2020
Protection of the Transplant Kidney from Preservation Injury by Inhibition of Matrix Metalloproteinases, Hanbin Lin, 2016
Subthreshold nitric oxide synthase inhibition improves synergistic effects of subthreshold MMP ��2 MLCK ��mediated cardiomyocyte protection from hypoxic injury, Hanbin Lin, 2016
Inhibition of MMP-2 expression affects the levels of metabolic enzymes: Proteomic analysis of rat cardiomyocytes. Journal of Proteomics, Hanbin Lin, 2014
Inhibition of MMP-2 Expression with siRNA Increases Baseline Cardiomyocyte Contractility and Protects against Simulated Ischemic Reperfusion Injury, Hanbin Lin, 2014
Synergy in protection against cardiac ischemia/reperfusion injury: a novel therapeutic paradigm for the future, Hanbin Lin, 2013
Proteomic analysis of right and left cardiac ventricles under aerobic conditions and after ischemia/reperfusion, Hanbin Lin, 2012
Effect of the myosin light chain kinase inhibitor ML-7 on the proteome of hearts subjected to ischemia��reperfusion injury, Hanbin Lin, 2012

Cardiovascular Diseases Pharmacological Interventions Heart Health Drug Delivery Atherosclerosis Metabolic Cardiomyopathy Immune Response Cell Signaling Mitochondrial Function Cardiac Hypertrophy

Hong Yu - Wuhan University

Junzhu Wu - Wuhan University

Hongjing Guan - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us